Press review (April 30, 2011) – Revue de presse (30 avril 2011)

Priming the Body to Tackle Cancer

Melanoma, one of the most common cancers, is usually treated with surgery and aggressive chemotherapy. In a new, preliminary study, Dr. Marcus O. Butler, of Boston's Dana-Farber Cancer Institute, suggests a kinder, gentler way of treating melanoma, and perhaps other cancers, using the body's own defense system..

By Karen Weintraub. In MIT Technology Review

http://www.technologyreview.com/biomedicine/37480/?p1=A2&a=f

Removing Ovaries During Hysterectomy Won't Raise Other Health Risks: Study

Among women who have had a hysterectomy, those whose ovaries were also removed had a lower risk of subsequent ovarian cancer and no greater risks of heart disease, hip fractures or other types of cancer, a new study indicates.

By Maureen Salamon. In U.S. News & World Report

http://health.usnews.com/health-news/family-health/cancer/articles/2011/04/27/removing-ovaries-during-hysterectomy-wont-raise-other-health-risks-study

New Potential Biomarker and Therapeutic Target for Aggressive Breast Cancer

Wei-Xing Zong, Ph.D., Associate Professor, Department of Molecular Genetics & Microbiology, and colleagues found that squamous cell carcinoma antigen (SCCA) expression correlated to both grade and stage of cancer..

Newswise

http://www.newswise.com/articles/new-potential-biomarker-and-therapeutic-target-for-aggressive-breast-cancer

'Urgent Need' for Research on Cancer Among Minorities: U.S. Report

The United States urgently needs to expand research and improve understanding of cancer among minority populations, according to a special report issued Thursday by the President's Cancer Panel.

By Madonna Behen. In U.S. News & World Report

http://health.usnews.com/health-news/family-health/cancer/articles/2011/04/28/urgent-need-for-research-on-cancer-among-minorities-us-report

Zytiga Approved for Advanced Prostate Cancer

Zytiga (abiraterone acetate), used in combination with the steroid prednisone, has been approved to treat advanced prostate cancer, the US Food and Drug Administration said in a news release.

In U.S. News & World Report

http://health.usnews.com/health-news/family-health/cancer/articles/2011/04/29/zytiga-approved-for-advanced-prostate-cancer

Use of costly breast cancer therapy strongly influenced by reimbursement policy

What Medicare would pay for and where a radiation oncologist practiced were two factors that strongly influenced the choice of intensity-modulated radiation therapy (IMRT) for treating breast cancer, according to an article published April 29 online in the Journal of the National Cancer Institute.

ScienceBlog.com

http://scienceblog.com/44813/use-of-costly-breast-cancer-therapy-strongly-influenced-by-reimbursement-policy/

Dur, dur de revenir au travail après un cancer

On se fatigue plus vite, on a moins confiance en soi, peur de la récidive, et au travail, on se sent pénalisé : le retour dans l'entreprise après un cancer, effectif pour 8 personnes sur dix, est souvent difficile, ont constaté des cancérologues et médecins du travail.

Par Christine Courcol. AFP

http://www.google.com/hostednews/afp/article/ALeqM5iSGUJFLAB8MBfFqlejAtul7yoVmw?docId=CNG.0dec2bfe2cda798ca90e3184832dd769.331

Les oméga-3 seraient-ils dangereux pour la prostate ?

Selon une étude menée sur plus de 3.000 hommes, les formes agressives du cancer de la prostate pourraient être favorisées par une concentration sanguine élevée d'oméga-3.

Par Claire Peltier. Dans Futura Sciences

http://www.futura-sciences.com/fr/news/t/medecine/d/les-omega-3-seraient-ils-dangereux-pour-la-prostate_29755/

Tchernobyl : le bilan sanitaire fait toujours débat

25 ans après la catastrophe de Tchernobyl, le bilan sanitaire fait toujours débat.

Euronews

http://fr.euronews.net/2011/04/26/tchernobyl-le-bilan-sanitaire-fait-toujours-debat/

L’haptoglobine, marqueur potentiel du cancer du pancréas

Les résultats publiés par David Lubman et coll. dans le « Journal of Proteome Research » suggèrent qu’un test sanguin pourrait être développé pour détecter le cancer pancréatique.

Le Quotidien du Médecin

http://www.lequotidiendumedecin.fr/specialites/l-haptoglobine-marqueur-potentiel-du-cancer-du-pancreas